On top of this, the AI giant claims that Claude Sonnet 5 is better at refusing malicious requests, while also resisting hijack attempts in prompt injection attacks. It also presented lower rates of ...
AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results